Premium
Use of Iridium‐192 in interstitial tumor therapy
Author(s) -
Stella Joseph G.,
Kramer Simon,
Mansfield Carl M.,
Suntharalingam N.
Publication year - 1973
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197309)32:3<665::aid-cncr2820320320>3.0.co;2-l
Subject(s) - medicine , iridium , oncology , biochemistry , chemistry , catalysis
Iridium‐192 as a radium substitute in the interstitial treatment of malignant tumors has been used extensively by Henschke in this country and Pierquin et al. in France. Using Iridium‐192, platinum iridium wire supplied by the Atomic Energy Commission of France, 108 patients have been treated using the techniques described by Henschke and Pierquin. This experience in a wide variety of clinical situations has been favorable. Greater flexibility and adaptability, decreased hazards to personnel, good tumor control and acceptable minor complications are advantages of afterloaded iridium‐192 wire tumor implants.